PHIBRO ANIMAL HEALTH CORP
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$38.88
+0.05%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+8.4%
3 months
+5.0%
6 months
-28.7%
1 year
-6.0%
Year to date
+5.0%
52-week range
$28.33 – $59.18
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.58B
P/E
15.8
P/B
4.1
P/S
1
Revenue
$1.52B
Net income
$99.72M
Diluted EPS
2.43
Gross margin
33.80%
Net margin
6.60%
Return on equity
28.70%
Total debt
$732.79M
Cash
$61.42M
Free cash flow
$9.87M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $396.75M | $21.71M | 33.90% | 5.50% | $5.23M |
| Mar 31, 2026 | $383.54M | $24.02M | 32.80% | 6.30% | $890K |
| Dec 31, 2025 | $373.91M | $27.46M | 35.50% | 7.30% | $8.26M |
| Sep 30, 2025 | $363.89M | $26.53M | 32.90% | 7.30% | -$4.5M |
| Jun 30, 2025 | $378.7M | $17.22M | 29.00% | 4.50% | $8.13M |
| Mar 31, 2025 | $347.83M | $20.88M | 30.10% | 6.00% | $35.41M |
| Dec 31, 2024 | $309.26M | $3.19M | 32.90% | 1.00% | -$4.75M |
| Sep 30, 2024 | $260.43M | $6.98M | 32.10% | 2.70% | $3.04M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent PAHC news
All market newsNo ticker-linked stories are in the current archive.